
Taofiq A. Solola
Examiner (ID: 15817)
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1613, 1622, 1626, 1625 |
| Total Applications | 3197 |
| Issued Applications | 2337 |
| Pending Applications | 273 |
| Abandoned Applications | 640 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11949419
[patent_doc_number] => 20170253571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'Use of Halogens in the Production of 2,5-Furandicarboxylic Acid'
[patent_app_type] => utility
[patent_app_number] => 15/517577
[patent_app_country] => US
[patent_app_date] => 2015-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9654
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15517577
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/517577 | Use of Halogens in the Production of 2,5-Furandicarboxylic Acid | Oct 8, 2015 | Abandoned |
Array
(
[id] => 12526716
[patent_doc_number] => 10005748
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-26
[patent_title] => 5-hydroxymethylfurfural production using a multi-fluorinated alcohol compound
[patent_app_type] => utility
[patent_app_number] => 15/517548
[patent_app_country] => US
[patent_app_date] => 2015-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7548
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 200
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15517548
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/517548 | 5-hydroxymethylfurfural production using a multi-fluorinated alcohol compound | Oct 8, 2015 | Issued |
Array
(
[id] => 11749201
[patent_doc_number] => 09707198
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-18
[patent_title] => 'Compositions comprising amino acids for use in the treatment of stroke in patients with dysphagia'
[patent_app_type] => utility
[patent_app_number] => 14/878100
[patent_app_country] => US
[patent_app_date] => 2015-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14456
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14878100
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/878100 | Compositions comprising amino acids for use in the treatment of stroke in patients with dysphagia | Oct 7, 2015 | Issued |
Array
(
[id] => 11993883
[patent_doc_number] => 20170298038
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'PROCESS FOR THE PREPARATION OF GAMMA-VALEROLACTONE BY CATALYTIC HYDROGENATION OF LEVULINIC ACID USING Ru-BASED CATALYSTS'
[patent_app_type] => utility
[patent_app_number] => 15/518217
[patent_app_country] => US
[patent_app_date] => 2015-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6667
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15518217
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/518217 | Process for the preparation of gamma-valerolactone by catalytic hydrogenation of levulinic acid using Ru-based catalysts | Oct 7, 2015 | Issued |
Array
(
[id] => 11949420
[patent_doc_number] => 20170253572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'USE OF AN ACIDIC SOLVENT AND WATER IN THE PRODUCTION OF 2,5-FURANDICARBOXYLIC ACID'
[patent_app_type] => utility
[patent_app_number] => 15/517584
[patent_app_country] => US
[patent_app_date] => 2015-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9650
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15517584
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/517584 | USE OF AN ACIDIC SOLVENT AND WATER IN THE PRODUCTION OF 2,5-FURANDICARBOXYLIC ACID | Oct 6, 2015 | Abandoned |
Array
(
[id] => 11943197
[patent_doc_number] => 20170247348
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => 'USE OF CARBOXYLIC ACIDS IN THE PRODUCITON OF 2,5-FURANDICARBOXYLIC ACID'
[patent_app_type] => utility
[patent_app_number] => 15/517564
[patent_app_country] => US
[patent_app_date] => 2015-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9645
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15517564
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/517564 | USE OF CARBOXYLIC ACIDS IN THE PRODUCITON OF 2,5-FURANDICARBOXYLIC ACID | Oct 6, 2015 | Abandoned |
Array
(
[id] => 11949422
[patent_doc_number] => 20170253573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'USE OF BROMINE IONS IN THE PRODUCTION OF 2,5-FURANDICARBOXYLIC ACID'
[patent_app_type] => utility
[patent_app_number] => 15/517599
[patent_app_country] => US
[patent_app_date] => 2015-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9651
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15517599
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/517599 | USE OF BROMINE IONS IN THE PRODUCTION OF 2,5-FURANDICARBOXYLIC ACID | Oct 6, 2015 | Abandoned |
Array
(
[id] => 12000101
[patent_doc_number] => 20170304255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'PPAR AGONISTS, COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/517893
[patent_app_country] => US
[patent_app_date] => 2015-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 32014
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15517893
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/517893 | PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof | Oct 6, 2015 | Issued |
Array
(
[id] => 10634480
[patent_doc_number] => 09351968
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2016-05-31
[patent_title] => 'Methods of treating developmental disorders using pipradrol'
[patent_app_type] => utility
[patent_app_number] => 14/876110
[patent_app_country] => US
[patent_app_date] => 2015-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5988
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14876110
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/876110 | Methods of treating developmental disorders using pipradrol | Oct 5, 2015 | Issued |
Array
(
[id] => 10749681
[patent_doc_number] => 20160095832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-07
[patent_title] => 'TOPICAL COMPOSITION FOR PAIN RELIEF'
[patent_app_type] => utility
[patent_app_number] => 14/872581
[patent_app_country] => US
[patent_app_date] => 2015-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 732
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14872581
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/872581 | TOPICAL COMPOSITION FOR PAIN RELIEF | Sep 30, 2015 | Abandoned |
Array
(
[id] => 12029440
[patent_doc_number] => 20170319539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-09
[patent_title] => 'Amorphous Empagliflozin'
[patent_app_type] => utility
[patent_app_number] => 15/515787
[patent_app_country] => US
[patent_app_date] => 2015-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4293
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15515787
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/515787 | Amorphous Empagliflozin | Sep 30, 2015 | Abandoned |
Array
(
[id] => 10782969
[patent_doc_number] => 20160129125
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-12
[patent_title] => 'COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES'
[patent_app_type] => utility
[patent_app_number] => 14/872179
[patent_app_country] => US
[patent_app_date] => 2015-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 14629
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14872179
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/872179 | Compounds and methods for trans-membrane delivery of molecules | Sep 30, 2015 | Issued |
Array
(
[id] => 11993880
[patent_doc_number] => 20170298035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'RELATING TO ETHYLENE OXIDE RECOVERY'
[patent_app_type] => utility
[patent_app_number] => 15/515609
[patent_app_country] => US
[patent_app_date] => 2015-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5732
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15515609
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/515609 | Relating to ethylene oxide recovery | Sep 28, 2015 | Issued |
Array
(
[id] => 12283042
[patent_doc_number] => 09931327
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-03
[patent_title] => Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
[patent_app_type] => utility
[patent_app_number] => 14/863915
[patent_app_country] => US
[patent_app_date] => 2015-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46783
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 912
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14863915
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/863915 | Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors | Sep 23, 2015 | Issued |
Array
(
[id] => 13065373
[patent_doc_number] => 10053459
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-21
[patent_title] => Life-extending agent, life extension method using the life-extending agent, novel dual oxidase activator, method for activating dual oxidase, production of life-extending agent, and production of dual oxidase activator
[patent_app_type] => utility
[patent_app_number] => 15/512895
[patent_app_country] => US
[patent_app_date] => 2015-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 9548
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15512895
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/512895 | Life-extending agent, life extension method using the life-extending agent, novel dual oxidase activator, method for activating dual oxidase, production of life-extending agent, and production of dual oxidase activator | Sep 17, 2015 | Issued |
Array
(
[id] => 10822024
[patent_doc_number] => 20160168188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-16
[patent_title] => 'SYNTHESIS OF ENT-PROGESTERONE AND INTERMEDIATES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/855072
[patent_app_country] => US
[patent_app_date] => 2015-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13589
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14855072
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/855072 | SYNTHESIS OF ENT-PROGESTERONE AND INTERMEDIATES THEREOF | Sep 14, 2015 | Abandoned |
Array
(
[id] => 11987726
[patent_doc_number] => 20170291881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-12
[patent_title] => 'EFFICIENT AND SCALABLE SYNTHESIS OF 2-(1\'H-INDOLE-3\'-CARBONYL)-THIAZOLE-4-CARBOXYLIC ACID METHYL ESTER AND ITS STRUCTURAL ANALOGS'
[patent_app_type] => utility
[patent_app_number] => 15/509722
[patent_app_country] => US
[patent_app_date] => 2015-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8565
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15509722
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/509722 | Efficient and scalable synthesis of 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester and its structural analogs | Sep 9, 2015 | Issued |
Array
(
[id] => 13011675
[patent_doc_number] => 10028938
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-24
[patent_title] => Antiviral agents and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/508055
[patent_app_country] => US
[patent_app_date] => 2015-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 15
[patent_no_of_words] => 24046
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 299
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15508055
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/508055 | Antiviral agents and uses thereof | Sep 6, 2015 | Issued |
Array
(
[id] => 10476069
[patent_doc_number] => 20150361086
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-17
[patent_title] => 'HIGH-FLUIDITY NON-CAKING DIANHYDROHEXITOL PELLETS'
[patent_app_type] => utility
[patent_app_number] => 14/834603
[patent_app_country] => US
[patent_app_date] => 2015-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6720
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14834603
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/834603 | High-fluidity non-caking dianhydrohexitol pellets | Aug 24, 2015 | Issued |
Array
(
[id] => 11789498
[patent_doc_number] => 09399034
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2016-07-26
[patent_title] => 'Methods of sedation during critical care treatment'
[patent_app_type] => utility
[patent_app_number] => 14/834027
[patent_app_country] => US
[patent_app_date] => 2015-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8574
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14834027
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/834027 | Methods of sedation during critical care treatment | Aug 23, 2015 | Issued |